Estrogen, mitochondria, and growth of cancer and non-cancer cells

Quentin Felty1, Deodutta Roy

  • 1Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, AL, 35294-0022 USA. Droy@fiu.edu.

Journal of Carcinogenesis
|January 18, 2005
PubMed

Insights

Estrogen significantly impacts mitochondrial function, influencing cell growth. Understanding this estrogen-mitochondria interaction is key for developing therapies for estrogen-dependent diseases and cancer.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Mitochondria play a crucial role in cellular energy production and signaling.
  • Estrogen is a key hormone with diverse physiological effects, including impacts on cellular metabolism.
  • Mitochondrial dysfunction is implicated in various diseases, including cancer and metabolic disorders.

Purpose of the Study:

  • To review the multifaceted actions of estrogen on mitochondrial function.
  • To explore the implications of estrogen-mitochondrial interactions on cell growth and proliferation.
  • To highlight the relevance of mitochondrial signaling to the nucleus in disease pathogenesis.

Main Methods:

  • Literature review of existing research on estrogen and mitochondria.
  • Analysis of studies investigating estrogen's effects on mitochondrial respiration and biogenesis.
  • Examination of data on estrogen-induced mitochondrial signaling pathways.

Main Results:

  • Estrogen directly modulates mitochondrial activity, affecting ATP production and reactive oxygen species levels.
  • Estrogen signaling influences mitochondrial dynamics, including fusion and fission processes.
  • Mitochondrial-to-nuclear signaling pathways are altered by estrogen, impacting gene expression related to cell growth.

Conclusions:

  • Estrogen's intricate relationship with mitochondria is central to its role in cell growth regulation.
  • Targeting estrogen-mitochondria interactions offers potential therapeutic strategies for estrogen-dependent diseases.
  • Further research into mitochondrial disorders and their link to estrogen action is warranted for cancer treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.